More than 600,000 bottles of a common blood pressure medication have been recalled in the U.S., and patients are urged to check their prescriptions immediately.
What Happened?
Pharmaceutical company Lupin Pharmaceuticals has voluntarily recalled over 616,000 bottles of Ramipril capsules (2.5 mg, 5 mg, and 10 mg). The recall began on October 23 after it was discovered that the active ingredient had been sourced from an unapproved vendor.
How Serious Is It?
The recall is classified as a Class II recall, which means the product may cause temporary or medically reversible health issues, but the likelihood of serious harm is considered low. Still, experts warn that patients should not ignore this recall.
Numbers Recalled
- 2.5 mg bottles: 112,770
- 5 mg bottles: 146,322
- 10 mg bottles: 357,414
Total: 616,506 bottles
What Should You Do?
- Check your medicine labels: If you’re taking Ramipril, look closely at the strength and batch information.
- Do not stop taking medication on your own: High blood pressure medicine is crucial—consult your doctor or pharmacist for a safe alternative.
- Return affected bottles: Pharmacies will guide you on proper returns and replacements.
Why It Matters
Ramipril is a widely used drug for treating high blood pressure and heart failure. Any disruption in quality or safety can affect thousands of patients who rely on it daily.
Bottom Line: If you or someone you know takes Ramipril, check the label now and contact your healthcare provider.
